We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Graco
GGG
$13.3B
| $838K | 0.1% |
9,660
-5,508
| -36% | -$433K |
|
302
Packaging Corp of America
PKG
$22.8B
| $836K | 0.1% |
5,134
+2,861
| +126% | +$450K |
|
303
ZIM Integrated Shipping Services
ZIM
$3.29B
| $827K | 0.1% |
83,745
+52,270
| +166% | +$439K |
|
304
Edison International
EIX
$27.2B
| $825K | 0.1% |
11,544
+8,365
| +263% | +$550K |
|
305
VeriSign
VRSN
$27.1B
| $820K | 0.09% |
3,979
+2,091
| +111% | +$435K |
|
306
ESAB
ESAB
$5.89B
| $820K | 0.09% |
+9,461
| New | +$717K |
|
307
Q2 Holdings
QTWO
$3.99B
| $817K | 0.09% |
18,823
+8,344
| +80% | +$296K |
|
308
Deutsche Bank
DB
$70.4B
| $816K | 0.09% |
+60,233
| New | +$709K |
|
309
Popular Inc
BPOP
$11.2B
| $809K | 0.09% |
+9,855
| New | +$698K |
|
310
ResMed
RMD
$32.4B
| $808K | 0.09% |
4,696
-61,238
| -93% | -$9.41M |
|
311
TE Connectivity
TEL
$62.9B
| $803K | 0.09% |
+5,718
| New | +$735K |
|
312
Zoetis
ZTS
$31.9B
| $803K | 0.09% |
+4,070
| New | +$721K |
|
|
THS
313
DELISTED
Treehouse Foods
THS
| $803K | 0.09% |
+19,374
| New | +$795K |
|
314
Remitly
RELY
$5.18B
| $802K | 0.09% |
41,311
+30,446
| +280% | +$682K |
|
315
KeyCorp
KEY
$24.8B
| $801K | 0.09% |
+55,640
| New | +$661K |
|
316
Amphastar Pharmaceuticals
AMPH
$877M
| $801K | 0.09% |
+12,948
| New | +$680K |
|
317
Calix
CALX
$2.49B
| $800K | 0.09% |
18,312
+2,910
| +19% | +$116K |
|
318
UGI
UGI
$7.77B
| $798K | 0.09% |
+32,423
| New | +$715K |
|
319
ABM Industries
ABM
$2.88B
| $795K | 0.09% |
+17,732
| New | +$749K |
|
320
California Resources
CRC
$4.66B
| $793K | 0.09% |
14,509
+1,599
| +12% | +$84.1K |
|
321
ServiceNow
NOW
$122B
| $789K | 0.09% |
5,585
-15,810
| -74% | -$1.99M |
|
322
Applied Industrial Technologies
AIT
$13.2B
| $789K | 0.09% |
+4,566
| New | +$740K |
|
323
American Airlines Group
AAL
$11B
| $783K | 0.09% |
56,988
-298,928
| -84% | -$3.75M |
|
324
Bumble
BMBL
$417M
| $781K | 0.09% |
+53,013
| New | +$752K |
|
325
Schrodinger
SDGR
$1.17B
| $780K | 0.09% |
21,790
-14,008
| -39% | -$406K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.